Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma

被引：5

作者：

Sun Fu-kang ^{[1
]}

He Hong-chao ^{[1
]}

Su Ting-wei ^{[2
]}

Zhou Wen-long ^{[1
]}

Huang Xin ^{[1
]}

Dai Jun ^{[1
]}

Shen Zhou-jun ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai 200025, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Endocrinol,Clin Ctr Shanghai Endocrine & Met, Shanghai 200025, Peoples R China

来源：

CHINESE MEDICAL JOURNAL | 2012年 / 125卷 / 12期

关键词：

sunitinib; targeted therapy; anti-angiogenesis; malignant pheochromocytoma; EFFICACY;

D O I：

10.3760/cma.j.issn.0366-6999.2012.12.027

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sporadic malignant pheochromocytoma, a rare disease with poor prognosis, is always difficult to treat due in part to lack of effective agents. We presented three patients with advanced malignant pheochromocytoma treated by sunitinib, which indicates that sunitinib is an effective agent for this malignancy.

引用

页码：2231 / 2234

页数：4

共 50 条

[41] The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
Michaelis, Martin
Paulus, Christina
Loeschmann, Nadine
Dauth, Stephanie
Stange, Elisabeth
Doerr, Hans Wilhelm
Nevels, Michael
Cinatl, Jindrich, Jr.
CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (06) : 1079 - 1090
[42] Editorial: Multi-targeted tyrosine kinase inhibitors in the treatment of cancer and neurodegenerative disorders
Sever, Belgin
Saso, Luciano
Tzoneva, Rumiana
Onnis, Valentina
Ciftci, Halilibrahim
FRONTIERS IN CHEMISTRY, 2024, 12
[43] A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy
Brian D. Ross
Youngsoon Jang
Amanda Welton
Christopher A. Bonham
Dilrukshika S. W. Palagama
Kevin Heist
Jagadish Boppisetti
Kasun P. Imaduwage
Tanner Robison
Leah R. King
Edward Z. Zhang
Cyrus Amirfazli
Kathryn E. Luker
Winston Y. Lee
Gary D. Luker
Thomas L. Chenevert
Marcian E. Van Dort
Nature Communications, 13
[44] Are all multi-targeted tyrosine kinase inhibitors created equal? An in vitro study of sunitinib and pazopanib in renal cell carcinoma cell lines
Canter, Daniel
Kutikov, Alexander
Golovine, Konstantin
Makhov, Petr
Simhan, Jay
Uzzo, Robert G.
Kolenko, Vladimir M.
CANADIAN JOURNAL OF UROLOGY, 2011, 18 (04) : 5819 - 5825
[45] Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases
Ji, Zhiqin
Ahmed, Asma A.
Albert, Daniel H.
Bouska, Jennifer J.
Bousquet, Peter F.
Cunha, George A.
Glaser, Keith B.
Guo, Jun
Li, Junling
Marcotte, Patrick A.
Moskey, Maria D.
Pease, Lori J.
Stewart, Kent D.
Yates, Melinda
Davidsen, Steven K.
Michaelides, Michael R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4326 - 4330
[46] ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
Jasinghe, Viraj J.
Xie, Zhigang
Zhou, Jianbiao
Khng, Jiaying
Poon, Lai-Fong
Senthilnathan, Palaniyandi
Glaser, Keith B.
Albert, Daniel H.
Davidsen, Steven K.
Chen, Chien-Shing
JOURNAL OF HEPATOLOGY, 2008, 49 (06) : 985 - 997
[47] Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, Tammy F.
Rupnick, Maria A.
Kerkela, Risto
Dallabrida, Susan M.
Zurakowski, David
Nguyen, Lisa
Woulfe, Kathleen
Pravda, Elke
Cassiola, Flavia
Desai, Jayesh
George, Suzanne
Morgan, Jeffrey A.
Harris, David M.
Ismail, Nesreen S.
Chen, Jey-Hsin
Schoen, Frederick J.
Van den Abbeele, Annick D.
Demetri, George D.
Force, Thomas
Chen, Ming Hui
LANCET, 2007, 370 (9604): : 2011 - 2019
[48] The multi-targeted kinase inhibitor Sorafenib inhibits Enterovirus 71 IRES activity
Peng, Y.
Gao, M.
Wang, X.
Zhu, M.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 453 - 453
[49] Activity of the multi-tyrosine kinase inhibitor sunitinib in neuroblastoma tumors.
Calero, R.
Serrano, R.
Avendano, L.
Poblet, E.
Ocana, A.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[50] Treatment of Disseminated Sporadic MTC with Sorafenib, a Novel Tyrosine Kinase Inhibitor
Fraenkel, M.
Grozinsky-Glasberg, S.
Barak, D.
Appelbaum, L.
Gross, D. J.
NEUROENDOCRINOLOGY, 2009, 90 (01) : 112 - 112

← 1 2 3 4 5 →